DE60034057D1 - Behandlung von menschlicher unfruchtbarkeit - Google Patents

Behandlung von menschlicher unfruchtbarkeit

Info

Publication number
DE60034057D1
DE60034057D1 DE60034057T DE60034057T DE60034057D1 DE 60034057 D1 DE60034057 D1 DE 60034057D1 DE 60034057 T DE60034057 T DE 60034057T DE 60034057 T DE60034057 T DE 60034057T DE 60034057 D1 DE60034057 D1 DE 60034057D1
Authority
DE
Germany
Prior art keywords
human
meiotic
barreness
treatment
oocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60034057T
Other languages
English (en)
Other versions
DE60034057T2 (de
Inventor
Christian Grondahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of DE60034057D1 publication Critical patent/DE60034057D1/de
Publication of DE60034057T2 publication Critical patent/DE60034057T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Registering, Tensioning, Guiding Webs, And Rollers Therefor (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60034057T 1999-11-25 2000-11-23 Behandlung von menschlicher unfruchtbarkeit Expired - Fee Related DE60034057T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK170599 1999-11-25
DKPA199901705 1999-11-25
PCT/DK2000/000647 WO2001038493A1 (en) 1999-11-25 2000-11-23 Treatment of human infertility

Publications (2)

Publication Number Publication Date
DE60034057D1 true DE60034057D1 (de) 2007-05-03
DE60034057T2 DE60034057T2 (de) 2007-12-06

Family

ID=8107372

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60034057T Expired - Fee Related DE60034057T2 (de) 1999-11-25 2000-11-23 Behandlung von menschlicher unfruchtbarkeit

Country Status (7)

Country Link
EP (1) EP1235899B1 (de)
JP (1) JP2003514580A (de)
AT (1) ATE357507T1 (de)
AU (1) AU1692901A (de)
DE (1) DE60034057T2 (de)
ES (1) ES2284542T3 (de)
WO (1) WO2001038493A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001248282A1 (en) * 2000-04-06 2001-10-23 Novo-Nordisk A/S Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro
JP2005518823A (ja) 2002-03-08 2005-06-30 マクギル・ユニバーシテイ 未成熟ヒト卵母細胞の体外成熟
WO2004035766A2 (en) * 2002-10-15 2004-04-29 Novo Nordisk A/S In vitro synchronisation of nuclear and cytoplasmatic maturation of oocytes involving addition and removal of phosphodiesterase type 3 inhibitor
AU2010246918A1 (en) * 2009-05-14 2011-12-01 Adelaide Research & Innovation Pty Ltd Methods for the collection and maturation of oocytes
CN102899286B (zh) * 2012-09-18 2015-05-27 中国农业大学 C型钠肽在促进牛卵母细胞体外成熟中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2199663C (en) * 1997-03-11 2004-08-10 Ruth Miriam Moses In vitro maturation and fertilization of mammalian oocytes
CA2333320A1 (en) * 1998-05-26 1999-12-02 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound

Also Published As

Publication number Publication date
DE60034057T2 (de) 2007-12-06
WO2001038493A1 (en) 2001-05-31
EP1235899A1 (de) 2002-09-04
ATE357507T1 (de) 2007-04-15
JP2003514580A (ja) 2003-04-22
EP1235899B1 (de) 2007-03-21
ES2284542T3 (es) 2007-11-16
AU1692901A (en) 2001-06-04

Similar Documents

Publication Publication Date Title
UY26249A1 (es) Moléculas pequenas útiles en el tratamiento de las enfermedades inflamatorias ley 17164 art. 127
BR0011130A (pt) Inibidores de metaloproteases
DE60223262D1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
BR0207811A (pt) Compostos de uréia aril e heteroaril substituìdos úteis no tratamento de doenças
TR200200381T2 (tr) Pirimidin-2,4,6-Trion Metalloproteinaz İnhibitorler.
DE60024660D1 (de) Menschliche rnase h und entsprechende oligonukleotidverbindungen
DE60011100D1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen
DK1119362T3 (da) Anvendelse af tetracyclinderivater til forögelse af interleukin-10-produktion
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
DE60023660D1 (de) Antizymmodulatoren sowie deren verwendung
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
ATE275400T1 (de) Verwendung von melatonin zur behandlung der androgenetischen und diffusen alopezie vom weiblichen typ
ATE292677T1 (de) Zusammensetzungen und verfahren zur inhibierung vom zellulären g2-übergang und sensitisierung von zellen gegen dna-schädigenden wirkstoffe
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
ATE222119T1 (de) Verwendung von erythropoietin zur behandlung von multiple myelom
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
ATE327973T1 (de) Polyamin-analoge als cytotoxische wirkstoffe
ATE357507T1 (de) Behandlung von menschlicher unfruchtbarkeit
DE60018704D1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
TR200200278T2 (tr) Kalsilitik bileşimler
DE69803383T2 (de) Selektive inhibitoren des faktors x, eine azepinonstruktur enthaltend
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee